Effect of inhaled prostaglandin D2 in normal and atopic subjects, and of pretreatment with leukotriene D4

Thorax

Volumn 52, Issue 6, 1997, Pages 513-518

  Sampson, Sally E ^a   Sampson, Anthony P ^b   Costello, John F ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Asthma; Leukotriene D1; Prostaglandin D2

Indexed keywords

LEUKOTRIENE D4; PROSTAGLANDIN D2;

ARTICLE; ASTHMA; ATOPY; BRONCHOSPASM; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG POTENCY; HUMAN; LUNG LAVAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030756090     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.6.513     Document Type: Article

References (36)

1. Barnes PJ, Chung KF, Page CP. Inflammatory mediators and asthma. Pharmacol Rev 1988;40:49-84.
2. Holgate ST. The mast cell and its function in allergic disease. Clin Allergy 1991;21(Suppl 3):11-16.
3. 2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 1982;129:1627-31.
4. 2 and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. J Immunol 1984;133:2138-44.
5. Miadonna A, Tedeschi A, Brasca C, Folco G, Sala A, Murphy RC. Mediator release after endobronchial antigen challenge in patients with respiratory disease. J Allergy Clin Immunol 1990;85:906-13.
6. 2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis 1990;142:126-32.
7. 2 in rat and human skin. Br J Pharmacol 1976;56:229-33.
8. 4) in human skin. J Invest Dermatol 1983;80:115-9.
9. Marom Z, Shelhamer JH, Kaliner M. The effects of arachidonic acid, monohydroxyeicosatetraenoic acid, and prostaglandins on the release of mucus glycoproteins from human airways in vitro. J Clin Invest 1981;67:1695-703.
10. 2 in normal and asthmatic men. N Engl J Med 1984;311: 209-13.
11. 2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis 1986;133:252-4.
12. 2 and histamine, methacholine or exercise in healthy and asthmatic subjects. Ann NY Acad Sci 1991;629:442-5.
13. 1 in asthmatic subjects. Br J Clin Pharmacol 1995;39: 119-23.
14. 2α in asthma. Am Rev Respir Dis 1987;136:1140-4.
15. Walters EH, Parrish RW, Bevan C, Smith AP. Induction of bronchial hypersensitivity: evidence for a role for prostaglandins. Thorax 1981;36:571-4.
16. 2α on bronchial sensitivity to inhaled histamine and methacholine in normal subjects. Br J Dis Chest 1984;78:168-73.
17. 2α. Thorax 1984;39:697(A).
18. 4 and platelet-activating factor on airway reactivity in normal subjects. Am Rev Respir Dis 1990;141:993-7.
19. 4 on the airway responsiveness to histamine in subjects with asthma and normal subjects. J Allergy Clin Immunol 1988;82:654-60.
20. 2 on airway caliber in asthma. J Appl Physiol 1989;66:304-12.
21. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977;7:235-43.
22. Britton J, Pavord I, Richards K, Knox A, Wisniewski A, Wahedna I, et al. Factors influencing the occurrence of airway hyperreactivity in the general population: the importance of atopy and airway calibre. Eur Respir J 1994; 7:881-7.
23. 4, methacholine, and histamine. Am Rev Respir Dis 1990;142:1112-8.
24. Djukanovic R, Lai CK, Wilson JW, Britten KM, Wilson SJ, Roche WR. Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic non-asthmatics and healthy controls. Eur Respir J 1992;5:538-44.
25. 2- and allergen-induced bronchoconstriction. J Appl Physiol 1989;66:1685-93.
26. 2 and histamine induced bronchconstriction in man. Br J Clin Pharmacol 1994;37:97-100.
27. Fujimura M, Kamio Y, Matsuda T, Hashimoto T. Bronchodilator effects of oxitropium bromide, fenoterol, and their combination in normal subjects. Clin Auton Res 1993;3: 31-5.
28. Wilson NM, Green S, Coe C, Barnes PJ. Duration of action by oxitropium bromide against cholinergic challenge. Eur J Respir Dis 1987;71:455-8.
29. Britton J, Hanley SP, Garrett HV, Hadfield JW, Tattersfield AE. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma. Thorax 1988;43:300-5.
30. Jongejan RC, De Jongste JC, Raatgeep RC, Stijnen T, Bonta IL, Kerrebijn KF. Effects of inflammatory mediators on the responsiveness of isolated human airways to methacholine. Am Rev Respir Dis 1990;142:1129-32.
31. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis of analogues to asthma attacks in aspirin sensitive patients. BMJ 1975;1:66-9.
32. Stevenson DD. Diagnosis, prevention and treatment of adverse reactions to aspirin and non-steroidal anti-inflammatory drugs. J Allerg Clin Immunol 1984;74:617-22.
33. Van Ardsel PP. Aspirin idiosyncrasy and tolerance. J Allergy Clin Immunol 1984;73:431-4.
34. 2 on allergen-induced asthma. Am Rev Respir Dis 1993;148:87-90.
35. 2. Lancet 1995;345:436-8.
36. Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop Bailey D, Croxtall J, et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA 1994;91:2046-50.